Correlation Between Santhera Pharmaceuticals and COSMO Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Santhera Pharmaceuticals and COSMO Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Santhera Pharmaceuticals and COSMO Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Santhera Pharmaceuticals Holding and COSMO Pharmaceuticals SA, you can compare the effects of market volatilities on Santhera Pharmaceuticals and COSMO Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Santhera Pharmaceuticals with a short position of COSMO Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Santhera Pharmaceuticals and COSMO Pharmaceuticals.

Diversification Opportunities for Santhera Pharmaceuticals and COSMO Pharmaceuticals

-0.71

Correlation Coefficient

Santhera Pharmaceuticals  COSMO Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Santhera and COSMO is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Santhera Pharmaceuticals Holdi and COSMO Pharmaceuticals SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSMO Pharmaceuticals and Santhera Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Santhera Pharmaceuticals Holding are associated (or correlated) with COSMO Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSMO Pharmaceuticals has no effect on the direction of Santhera Pharmaceuticals i.e., Santhera Pharmaceuticals and COSMO Pharmaceuticals go up and down completely randomly.

Pair Corralation between Santhera Pharmaceuticals and COSMO Pharmaceuticals

Assuming the 90 days trading horizon Santhera Pharmaceuticals is expected to generate 27.55 times less return on investment than COSMO Pharmaceuticals. But when comparing it to its historical volatility, Santhera Pharmaceuticals Holding is 1.03 times less risky than COSMO Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. COSMO Pharmaceuticals SA is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  4,489  in COSMO Pharmaceuticals SA on April 23, 2025 and sell it today you would earn a total of  1,711  from holding COSMO Pharmaceuticals SA or generate 38.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Santhera Pharmaceuticals Holdi  vs.  COSMO Pharmaceuticals SA

Santhera Pharmaceuticals

Risk-Adjusted Performance

Weak

Over the last 90 days Santhera Pharmaceuticals Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Santhera Pharmaceuticals is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

COSMO Pharmaceuticals

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in COSMO Pharmaceuticals SA are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, COSMO Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Santhera Pharmaceuticals and COSMO Pharmaceuticals

The main advantage of trading using opposite Santhera Pharmaceuticals and COSMO Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Santhera Pharmaceuticals position performs unexpectedly, COSMO Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSMO Pharmaceuticals will offset losses from the drop in COSMO Pharmaceuticals' long position.

The idea behind Santhera Pharmaceuticals Holding and COSMO Pharmaceuticals SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.